Source: CureToday articles
Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.
Recent Content
- Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care
- New Options for ER+ Breast Cancer Spotlighted at Patient Event
- Asembia’s AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers
- A Digital Detox for the Soul with Lynch Syndrome
- NCPA Urges DOGE to Examine PBMs for Waste, Fraud, and Abuse
- Decipher Prostate Test Now Available for Metastatic Prostate Cancer
- Pyrotinib-Based Therapy May Improve Survival in Patients With HER2+ Breast Cancer and Liver Metastases
- Many Patients With Elevated LDL Cholesterol Are Not Prescribed Lipid-Lowering Medication
- Survey Respondents Report Dietary Modifications Help Relieve Endometriosis-Related Pain
- The Benefits and Challenges of Subcutaneous Injection in Cancer Care